| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Additive effects of drug transporter genetic polymorphisms on irinotecan pharmacokinetics/pharmacodynamics in Japanese cancer patients
|
Sai, Kimie
|
|
2009
|
66 |
1 |
p. 95-105
|
artikel
|
| 2 |
A dose-finding and pharmacodynamic study of bortezomib in combination with weekly paclitaxel in patients with advanced solid tumors
|
Ramaswamy, Bhuvaneswari
|
|
2009
|
66 |
1 |
p. 151-158
|
artikel
|
| 3 |
A multi-center phase II study of docetaxel plus cisplatin as first-line therapy in patients with metastatic squamous cell esophageal cancer
|
Kim, Jin Young
|
|
2009
|
66 |
1 |
p. 31-36
|
artikel
|
| 4 |
A phase I dose-escalation and bioavailability study of oral and intravenous formulations of erlotinib (Tarceva®, OSI-774) in patients with advanced solid tumors of epithelial origin
|
Ranson, M.
|
|
2009
|
66 |
1 |
p. 53-58
|
artikel
|
| 5 |
A phase I/II study of oxaliplatin and paclitaxel in patients with non-resectable cancer of the oesophagus and adenocarcinoma of the gastro-oesophageal junction: a study of the Arbeitsgemeinschaft Internistische Onkologie
|
Kaechele, Volker
|
|
2010
|
66 |
1 |
p. 191-195
|
artikel
|
| 6 |
A phase-II study of combination of pegylated interferon alfa-2a and capecitabine in locally advanced or metastatic renal cell cancer
|
Sunela, Kaisa Leea
|
|
2009
|
66 |
1 |
p. 59-67
|
artikel
|
| 7 |
A phase I study of oral panobinostat alone and in combination with docetaxel in patients with castration-resistant prostate cancer
|
Rathkopf, Dana
|
|
2010
|
66 |
1 |
p. 181-189
|
artikel
|
| 8 |
Dihydroartemisinin improves the efficiency of chemotherapeutics in lung carcinomas in vivo and inhibits murine Lewis lung carcinoma cell line growth in vitro
|
Zhou, Hui-Jun
|
|
2009
|
66 |
1 |
p. 21-29
|
artikel
|
| 9 |
Effects of extracellular purines on cytotoxicity of methotrexate
|
Chong, Li
|
|
2009
|
66 |
1 |
p. 121-127
|
artikel
|
| 10 |
Feasibility study for biweekly administration of cisplatin plus gemcitabine as adjuvant-chemotherapy for completely resected non-small cell lung cancer
|
Yamaguchi, Masafumi
|
|
2009
|
66 |
1 |
p. 107-112
|
artikel
|
| 11 |
Gef gene therapy enhances the therapeutic efficacy of doxorubicin to combat growth of MCF-7 breast cancer cells
|
Prados, Jose
|
|
2009
|
66 |
1 |
p. 69-78
|
artikel
|
| 12 |
High endoplasmic reticulum activity renders multiple myeloma cells hypersensitive to mitochondrial inhibitors
|
Kurtoglu, Metin
|
|
2009
|
66 |
1 |
p. 129-140
|
artikel
|
| 13 |
Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models
|
Gabizon, Alberto
|
|
2009
|
66 |
1 |
p. 43-52
|
artikel
|
| 14 |
Inhibition of angiotensin II receptor 1 limits tumor-associated angiogenesis and attenuates growth of murine melanoma
|
Otake, Andréia Hanada
|
|
2009
|
66 |
1 |
p. 79-87
|
artikel
|
| 15 |
Meta-analysis of incidence and risk of hypokalemia with cetuximab-based therapy for advanced cancer
|
Cao, Yunfei
|
|
2009
|
66 |
1 |
p. 37-42
|
artikel
|
| 16 |
“Metronomic” chemotherapy in advanced soft tissue sarcomas
|
Italiano, Antoine
|
|
2010
|
66 |
1 |
p. 197-202
|
artikel
|
| 17 |
N3-o-toluyl-fluorouracil inhibits human hepatocellular carcinoma cell growth via sustained release of 5-FU
|
Zhang, Xiaofan
|
|
2009
|
66 |
1 |
p. 11-19
|
artikel
|
| 18 |
Peroxisome proliferator-activated receptor γ-dependent activity of indole ring-substituted 1,1-bis(3′-indolyl)-1-(p-biphenyl)methanes in cancer cells
|
Guo, Jingjing
|
|
2009
|
66 |
1 |
p. 141-150
|
artikel
|
| 19 |
Phase I study of combination therapy with weekly paclitaxel and cyclophosphamide for advanced or recurrent breast cancer
|
Masuda, Norikazu
|
|
2009
|
66 |
1 |
p. 89-94
|
artikel
|
| 20 |
Ruthenium-based chemotherapeutics: are they ready for prime time?
|
Antonarakis, Emmanuel S.
|
|
2010
|
66 |
1 |
p. 1-9
|
artikel
|
| 21 |
Sensitivity of breast cancer cell lines to recombinant thiaminase I
|
Liu, Shuqian
|
|
2009
|
66 |
1 |
p. 171-179
|
artikel
|
| 22 |
Sorafenib in combination with carboplatin and paclitaxel as neoadjuvant chemotherapy in patients with advanced ovarian cancer
|
Pölcher, Martin
|
|
2010
|
66 |
1 |
p. 203-207
|
artikel
|
| 23 |
The effects of drug transporter inhibitors on the pharmacokinetics and tissue distribution of methotrexate in normal and tumor-bearing mice: a microdialysis study
|
Sani, Shabnam N.
|
|
2009
|
66 |
1 |
p. 159-169
|
artikel
|
| 24 |
Usefulness of chemotherapy beyond the second line for metastatic breast cancer: a therapeutic challenge
|
Vauléon, Elodie
|
|
2009
|
66 |
1 |
p. 113-120
|
artikel
|
Tijdschrift beschrijving